Ideas
Writing and thinking from the Workomics team
The Latest
Improving accessibility
A UX design lens helps us create digital materials that are as intuitive and accessible as possible. This can make a big difference, especially in advanced therapies for rare and complex diseases, where patients are often quite sick and faced with increasingly difficult treatment decisions.
Once a month, we send out a newsletter of work-related ideas. Get our next edition delivered to your inbox.
Women Entrepreneurs Interview Series
We love to get inspired by other entrepreneurs. Our ongoing series of interviews with women business owners explores how and why they built their companies.
“I want to hang my hat on me”
Krista Lee Hynes, co-founder and managing partner at Ignite Financial, talks about her journey from theatre to financial planning, and why she has always bet on herself.
A new comfort zone
Shiri Levy, co-founder and Chief Scientific Officer at Histone Therapeutics, talks about building a biotech to bring a genetic medicine to market.
Running shoes designed for women
Lindsay Housman, CEO of Hettas, talks about researching and designing a running shoe specifically for women, along with her philosophy on flexible work, and the challenges of fundraising as a female founder.
Other ideas worth exploring
Improving accessibility
A UX design lens helps us create digital materials that are as intuitive and accessible as possible. This can make a big difference, especially in advanced therapies for rare and complex diseases, where patients are often quite sick and faced with increasingly difficult treatment decisions.
Caregiver-Friendly Workplaces
Back to Ideas An employee steps out to take a call. Her dad has Alzheimer’s and she is working on finding him a new nursing home facility,...
Clarifying clinical trial results
For brands, communicating clinical trial results is usually paramount—the clinical efficacy data, balanced by the side effects observed, is the foundation of the product’s value proposition for patients. But clinical trial data is typically complex, and can be difficult for patients to understand.
Redesigning Important Safety Information (ISI) for advanced therapies
Important Safety Information appears throughout branded patient marketing materials. It captures key information that patients with advanced and complex diseases want to know, and supports informed consent for important treatment decisions. Countless hours of co-creation time with patients, caregivers, HCPs, and subject matter experts has helped us think differently about how we can communicate ISI to patients.
Elevating visual strategy
The visual choices brands make in their patient marketing materials can play a bigger role than simply conveying a consistent and familiar brand identity.
Thinking holistically about the patient experience
Patients with rare and complex diseases need brand marketing materials that offer concrete support. That’s why our approach is built on clear and effective communication, holistically integrating UX, visuals, clinical trial data, and important safety information.